nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLC22A7—Glyburide—type 2 diabetes mellitus	0.0986	0.225	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0819	0.187	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.073	0.167	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0621	0.142	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Metformin—type 2 diabetes mellitus	0.0425	0.097	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0419	0.0957	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Losartan—type 2 diabetes mellitus	0.0384	0.0875	CbGbCtD
Dinoprost Tromethamine—TBXA2R—artery—type 2 diabetes mellitus	0.00831	0.0819	CbGeAlD
Dinoprost Tromethamine—TBXA2R—endothelium—type 2 diabetes mellitus	0.00702	0.0692	CbGeAlD
Dinoprost Tromethamine—GALR3—retina—type 2 diabetes mellitus	0.00577	0.0569	CbGeAlD
Dinoprost Tromethamine—PTGIR—artery—type 2 diabetes mellitus	0.00451	0.0444	CbGeAlD
Dinoprost Tromethamine—PTGIR—endothelium—type 2 diabetes mellitus	0.00381	0.0375	CbGeAlD
Dinoprost Tromethamine—TBXA2R—cardiovascular system—type 2 diabetes mellitus	0.00289	0.0285	CbGeAlD
Dinoprost Tromethamine—TBXA2R—cortex of kidney—type 2 diabetes mellitus	0.00275	0.0271	CbGeAlD
Dinoprost Tromethamine—TBXA2R—adipose tissue—type 2 diabetes mellitus	0.00255	0.0251	CbGeAlD
Dinoprost Tromethamine—PTGER1—kidney—type 2 diabetes mellitus	0.00248	0.0244	CbGeAlD
Dinoprost Tromethamine—PTGER1—pancreas—type 2 diabetes mellitus	0.00246	0.0243	CbGeAlD
Dinoprost Tromethamine—PTGER3—kidney—type 2 diabetes mellitus	0.00217	0.0214	CbGeAlD
Dinoprost Tromethamine—PTGER3—adipose tissue—type 2 diabetes mellitus	0.00196	0.0193	CbGeAlD
Dinoprost Tromethamine—HPGDS—cardiovascular system—type 2 diabetes mellitus	0.00192	0.0189	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—islet of Langerhans—type 2 diabetes mellitus	0.00189	0.0187	CbGeAlD
Dinoprost Tromethamine—HPGDS—kidney—type 2 diabetes mellitus	0.00188	0.0185	CbGeAlD
Dinoprost Tromethamine—HPGDS—pancreas—type 2 diabetes mellitus	0.00187	0.0184	CbGeAlD
Dinoprost Tromethamine—TBXA2R—liver—type 2 diabetes mellitus	0.00179	0.0176	CbGeAlD
Dinoprost Tromethamine—SLC22A11—nephron tubule—type 2 diabetes mellitus	0.0017	0.0167	CbGeAlD
Dinoprost Tromethamine—HPGDS—adipose tissue—type 2 diabetes mellitus	0.00169	0.0167	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—retina—type 2 diabetes mellitus	0.00163	0.0161	CbGeAlD
Dinoprost Tromethamine—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.0016	0.0158	CbGeAlD
Dinoprost Tromethamine—PTGFR—adipose tissue—type 2 diabetes mellitus	0.00157	0.0154	CbGeAlD
Dinoprost Tromethamine—PTGIR—cardiovascular system—type 2 diabetes mellitus	0.00157	0.0154	CbGeAlD
Dinoprost Tromethamine—PTGIR—kidney—type 2 diabetes mellitus	0.00153	0.0151	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—nephron tubule—type 2 diabetes mellitus	0.00152	0.015	CbGeAlD
Dinoprost Tromethamine—PTGIR—pancreas—type 2 diabetes mellitus	0.00152	0.015	CbGeAlD
Dinoprost Tromethamine—SLC22A11—kidney—type 2 diabetes mellitus	0.00149	0.0147	CbGeAlD
Dinoprost Tromethamine—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.00148	0.0145	CbGeAlD
Dinoprost Tromethamine—SLC22A7—kidney—type 2 diabetes mellitus	0.00146	0.0144	CbGeAlD
Dinoprost Tromethamine—SLC22A11—cortex of kidney—type 2 diabetes mellitus	0.00145	0.0143	CbGeAlD
Dinoprost Tromethamine—SLC22A7—cortex of kidney—type 2 diabetes mellitus	0.00142	0.014	CbGeAlD
Dinoprost Tromethamine—PTGIR—adipose tissue—type 2 diabetes mellitus	0.00138	0.0136	CbGeAlD
Dinoprost Tromethamine—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.00137	0.0135	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—kidney—type 2 diabetes mellitus	0.00135	0.0133	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—kidney—type 2 diabetes mellitus	0.00134	0.0132	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—pancreas—type 2 diabetes mellitus	0.00133	0.0131	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—cortex of kidney—type 2 diabetes mellitus	0.00132	0.013	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—cortex of kidney—type 2 diabetes mellitus	0.0013	0.0129	CbGeAlD
Dinoprost Tromethamine—SLC22A2—kidney—type 2 diabetes mellitus	0.0013	0.0128	CbGeAlD
Dinoprost Tromethamine—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.00126	0.0124	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—adipose tissue—type 2 diabetes mellitus	0.00122	0.012	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—adipose tissue—type 2 diabetes mellitus	0.00121	0.0119	CbGeAlD
Dinoprost Tromethamine—HPGDS—liver—type 2 diabetes mellitus	0.00119	0.0117	CbGeAlD
Dinoprost Tromethamine—PTGFR—liver—type 2 diabetes mellitus	0.0011	0.0108	CbGeAlD
Dinoprost Tromethamine—PTGIR—liver—type 2 diabetes mellitus	0.000968	0.00954	CbGeAlD
Dinoprost Tromethamine—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000958	0.00945	CbGeAlD
Dinoprost Tromethamine—SLC22A11—liver—type 2 diabetes mellitus	0.000944	0.0093	CbGeAlD
Dinoprost Tromethamine—Dinoprostone—CYP11A1—type 2 diabetes mellitus	0.000934	0.471	CrCbGaD
Dinoprost Tromethamine—SLC22A7—liver—type 2 diabetes mellitus	0.000921	0.00908	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—liver—type 2 diabetes mellitus	0.000854	0.00842	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—liver—type 2 diabetes mellitus	0.000846	0.00834	CbGeAlD
Dinoprost Tromethamine—SLC22A8—kidney—type 2 diabetes mellitus	0.000842	0.0083	CbGeAlD
Dinoprost Tromethamine—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.00082	0.00808	CbGeAlD
Dinoprost Tromethamine—Tafluprost—PTGS2—type 2 diabetes mellitus	0.000706	0.356	CrCbGaD
Dinoprost Tromethamine—Dinoprostone—CYP1A2—type 2 diabetes mellitus	0.000343	0.173	CrCbGaD
Dinoprost Tromethamine—Chills—Irbesartan—type 2 diabetes mellitus	0.000335	0.00154	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000334	0.00154	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000334	0.00154	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000334	0.00154	CcSEcCtD
Dinoprost Tromethamine—Infection—Gliclazide—type 2 diabetes mellitus	0.000333	0.00154	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000333	0.00153	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000333	0.00153	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000332	0.00153	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000332	0.00153	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000331	0.00152	CcSEcCtD
Dinoprost Tromethamine—Cough—Valsartan—type 2 diabetes mellitus	0.00033	0.00152	CcSEcCtD
Dinoprost Tromethamine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00033	0.00152	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000328	0.00151	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000326	0.0015	CcSEcCtD
Dinoprost Tromethamine—Cough—Orlistat—type 2 diabetes mellitus	0.000326	0.0015	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000325	0.0015	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000324	0.00149	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000324	0.00149	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000323	0.00149	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000323	0.00149	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000323	0.00149	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000322	0.00148	CcSEcCtD
Dinoprost Tromethamine—Sweating—Ramipril—type 2 diabetes mellitus	0.000321	0.00148	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000321	0.00148	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000321	0.00148	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000319	0.00147	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000319	0.00147	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000318	0.00147	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000318	0.00146	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000316	0.00146	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000314	0.00145	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000314	0.00144	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000312	0.00144	CcSEcCtD
Dinoprost Tromethamine—Malaise—Metformin—type 2 diabetes mellitus	0.00031	0.00143	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00031	0.00143	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000309	0.00142	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000309	0.00142	CcSEcCtD
Dinoprost Tromethamine—Syncope—Metformin—type 2 diabetes mellitus	0.000309	0.00142	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000308	0.00142	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000308	0.00142	CcSEcCtD
Dinoprost Tromethamine—Infection—Valsartan—type 2 diabetes mellitus	0.000306	0.00141	CcSEcCtD
Dinoprost Tromethamine—Rash—Glipizide—type 2 diabetes mellitus	0.000306	0.00141	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000306	0.00141	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000306	0.00141	CcSEcCtD
Dinoprost Tromethamine—Headache—Glipizide—type 2 diabetes mellitus	0.000304	0.0014	CcSEcCtD
Dinoprost Tromethamine—Shock—Valsartan—type 2 diabetes mellitus	0.000303	0.0014	CcSEcCtD
Dinoprost Tromethamine—Infection—Orlistat—type 2 diabetes mellitus	0.000303	0.00139	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000302	0.00139	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000301	0.00139	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000301	0.00139	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.0003	0.00138	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000299	0.00138	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000299	0.00138	CcSEcCtD
Dinoprost Tromethamine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000298	0.00137	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000298	0.00137	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Metformin—type 2 diabetes mellitus	0.000297	0.00137	CcSEcCtD
Dinoprost Tromethamine—Back pain—Losartan—type 2 diabetes mellitus	0.000296	0.00136	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000295	0.00136	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000295	0.00136	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000294	0.00135	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000293	0.00135	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Metformin—type 2 diabetes mellitus	0.000293	0.00135	CcSEcCtD
Dinoprost Tromethamine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000293	0.00135	CcSEcCtD
Dinoprost Tromethamine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000292	0.00134	CcSEcCtD
Dinoprost Tromethamine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000291	0.00134	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Metformin—type 2 diabetes mellitus	0.000289	0.00133	CcSEcCtD
Dinoprost Tromethamine—Nausea—Glipizide—type 2 diabetes mellitus	0.000289	0.00133	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000288	0.00133	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000288	0.00133	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000287	0.00132	CcSEcCtD
Dinoprost Tromethamine—Pain—Gliclazide—type 2 diabetes mellitus	0.000287	0.00132	CcSEcCtD
Dinoprost Tromethamine—Rash—Glimepiride—type 2 diabetes mellitus	0.000286	0.00132	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000286	0.00131	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000285	0.00131	CcSEcCtD
Dinoprost Tromethamine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000285	0.00131	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000285	0.00131	CcSEcCtD
Dinoprost Tromethamine—Headache—Glimepiride—type 2 diabetes mellitus	0.000284	0.00131	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000284	0.00131	CcSEcCtD
Dinoprost Tromethamine—Cough—Irbesartan—type 2 diabetes mellitus	0.000283	0.0013	CcSEcCtD
Dinoprost Tromethamine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000283	0.0013	CcSEcCtD
Dinoprost Tromethamine—Agitation—Losartan—type 2 diabetes mellitus	0.000281	0.00129	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00028	0.00129	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00028	0.00129	CcSEcCtD
Dinoprost Tromethamine—Infection—Metformin—type 2 diabetes mellitus	0.000279	0.00128	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000277	0.00128	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000277	0.00127	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000276	0.00127	CcSEcCtD
Dinoprost Tromethamine—Shock—Metformin—type 2 diabetes mellitus	0.000276	0.00127	CcSEcCtD
Dinoprost Tromethamine—Malaise—Losartan—type 2 diabetes mellitus	0.000276	0.00127	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000275	0.00127	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000275	0.00127	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000274	0.00126	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000274	0.00126	CcSEcCtD
Dinoprost Tromethamine—Syncope—Losartan—type 2 diabetes mellitus	0.000274	0.00126	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000274	0.00126	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000273	0.00126	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000272	0.00125	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000271	0.00125	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00027	0.00125	CcSEcCtD
Dinoprost Tromethamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000269	0.00124	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000269	0.00124	CcSEcCtD
Dinoprost Tromethamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000268	0.00124	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000268	0.00123	CcSEcCtD
Dinoprost Tromethamine—Cough—Losartan—type 2 diabetes mellitus	0.000267	0.00123	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000265	0.00122	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000265	0.00122	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000264	0.00122	CcSEcCtD
Dinoprost Tromethamine—Infection—Irbesartan—type 2 diabetes mellitus	0.000263	0.00121	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Metformin—type 2 diabetes mellitus	0.000262	0.00121	CcSEcCtD
Dinoprost Tromethamine—Shock—Irbesartan—type 2 diabetes mellitus	0.000261	0.0012	CcSEcCtD
Dinoprost Tromethamine—Pain—Orlistat—type 2 diabetes mellitus	0.000261	0.0012	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Losartan—type 2 diabetes mellitus	0.00026	0.0012	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00026	0.0012	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000259	0.00119	CcSEcCtD
Dinoprost Tromethamine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000258	0.00119	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000258	0.00119	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Losartan—type 2 diabetes mellitus	0.000257	0.00118	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000256	0.00118	CcSEcCtD
Dinoprost Tromethamine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000256	0.00118	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000256	0.00118	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000252	0.00116	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000252	0.00116	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000252	0.00116	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000251	0.00116	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00025	0.00115	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Metformin—type 2 diabetes mellitus	0.00025	0.00115	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000249	0.00115	CcSEcCtD
Dinoprost Tromethamine—Infection—Losartan—type 2 diabetes mellitus	0.000248	0.00114	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000248	0.00114	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000247	0.00114	CcSEcCtD
Dinoprost Tromethamine—Shock—Losartan—type 2 diabetes mellitus	0.000245	0.00113	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000244	0.00112	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000243	0.00112	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000243	0.00112	CcSEcCtD
Dinoprost Tromethamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000243	0.00112	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000241	0.00111	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000241	0.00111	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000241	0.00111	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000241	0.00111	CcSEcCtD
Dinoprost Tromethamine—Agitation—Ramipril—type 2 diabetes mellitus	0.000241	0.00111	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000238	0.0011	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000238	0.00109	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000237	0.00109	CcSEcCtD
Dinoprost Tromethamine—Malaise—Ramipril—type 2 diabetes mellitus	0.000236	0.00109	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000236	0.00109	CcSEcCtD
Dinoprost Tromethamine—Rash—Glyburide—type 2 diabetes mellitus	0.000236	0.00109	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000236	0.00108	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000235	0.00108	CcSEcCtD
Dinoprost Tromethamine—Syncope—Ramipril—type 2 diabetes mellitus	0.000235	0.00108	CcSEcCtD
Dinoprost Tromethamine—Headache—Glyburide—type 2 diabetes mellitus	0.000234	0.00108	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Losartan—type 2 diabetes mellitus	0.000233	0.00107	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000231	0.00107	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.00023	0.00106	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00023	0.00106	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00023	0.00106	CcSEcCtD
Dinoprost Tromethamine—Cough—Ramipril—type 2 diabetes mellitus	0.000229	0.00105	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000227	0.00105	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000227	0.00105	CcSEcCtD
Dinoprost Tromethamine—Pain—Irbesartan—type 2 diabetes mellitus	0.000227	0.00104	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000225	0.00103	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000224	0.00103	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000223	0.00103	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000222	0.00102	CcSEcCtD
Dinoprost Tromethamine—Nausea—Glyburide—type 2 diabetes mellitus	0.000222	0.00102	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000222	0.00102	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000222	0.00102	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Losartan—type 2 diabetes mellitus	0.000222	0.00102	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000221	0.00102	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Ramipril—type 2 diabetes mellitus	0.00022	0.00101	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000219	0.00101	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000218	0.00101	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000218	0.001	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000217	0.000998	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000216	0.000993	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000213	0.000983	CcSEcCtD
Dinoprost Tromethamine—Pain—Losartan—type 2 diabetes mellitus	0.000213	0.000982	CcSEcCtD
Dinoprost Tromethamine—Rash—Gliclazide—type 2 diabetes mellitus	0.000212	0.000974	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000211	0.000974	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000211	0.000972	CcSEcCtD
Dinoprost Tromethamine—Shock—Ramipril—type 2 diabetes mellitus	0.00021	0.000969	CcSEcCtD
Dinoprost Tromethamine—Headache—Gliclazide—type 2 diabetes mellitus	0.00021	0.000968	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00021	0.000965	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00021	0.000965	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000209	0.000961	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000208	0.00096	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000207	0.000952	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000206	0.000946	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000204	0.000939	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000204	0.000939	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000202	0.000928	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Metformin—type 2 diabetes mellitus	0.000201	0.000928	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Ramipril—type 2 diabetes mellitus	0.0002	0.00092	CcSEcCtD
Dinoprost Tromethamine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000199	0.000918	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Metformin—type 2 diabetes mellitus	0.000199	0.000915	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000197	0.000908	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000197	0.000908	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000196	0.000903	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000195	0.000899	CcSEcCtD
Dinoprost Tromethamine—Rash—Valsartan—type 2 diabetes mellitus	0.000194	0.000895	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000194	0.000894	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000194	0.000892	CcSEcCtD
Dinoprost Tromethamine—Headache—Valsartan—type 2 diabetes mellitus	0.000193	0.00089	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000192	0.000885	CcSEcCtD
Dinoprost Tromethamine—Rash—Orlistat—type 2 diabetes mellitus	0.000192	0.000885	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000192	0.000884	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000192	0.000884	CcSEcCtD
Dinoprost Tromethamine—Headache—Orlistat—type 2 diabetes mellitus	0.000191	0.000879	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000191	0.000878	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00019	0.000876	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Ramipril—type 2 diabetes mellitus	0.00019	0.000875	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000188	0.000863	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Metformin—type 2 diabetes mellitus	0.000186	0.000855	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000184	0.000846	CcSEcCtD
Dinoprost Tromethamine—Nausea—Valsartan—type 2 diabetes mellitus	0.000183	0.000843	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000181	0.000835	CcSEcCtD
Dinoprost Tromethamine—Nausea—Orlistat—type 2 diabetes mellitus	0.000181	0.000833	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Losartan—type 2 diabetes mellitus	0.000179	0.000824	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Metformin—type 2 diabetes mellitus	0.000179	0.000822	CcSEcCtD
Dinoprost Tromethamine—Rash—Metformin—type 2 diabetes mellitus	0.000177	0.000815	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000177	0.000815	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Losartan—type 2 diabetes mellitus	0.000176	0.000812	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000176	0.000811	CcSEcCtD
Dinoprost Tromethamine—Headache—Metformin—type 2 diabetes mellitus	0.000176	0.00081	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000175	0.000807	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000175	0.000805	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000171	0.000786	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000169	0.000778	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000169	0.000778	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000169	0.000776	CcSEcCtD
Dinoprost Tromethamine—Rash—Irbesartan—type 2 diabetes mellitus	0.000167	0.000769	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000167	0.000769	CcSEcCtD
Dinoprost Tromethamine—Nausea—Metformin—type 2 diabetes mellitus	0.000167	0.000768	CcSEcCtD
Dinoprost Tromethamine—Headache—Irbesartan—type 2 diabetes mellitus	0.000166	0.000764	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Losartan—type 2 diabetes mellitus	0.000165	0.000759	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Losartan—type 2 diabetes mellitus	0.000159	0.00073	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000158	0.000725	CcSEcCtD
Dinoprost Tromethamine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000157	0.000725	CcSEcCtD
Dinoprost Tromethamine—Rash—Losartan—type 2 diabetes mellitus	0.000157	0.000724	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000157	0.000723	CcSEcCtD
Dinoprost Tromethamine—Headache—Losartan—type 2 diabetes mellitus	0.000156	0.000719	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000153	0.000707	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000151	0.000697	CcSEcCtD
Dinoprost Tromethamine—Nausea—Losartan—type 2 diabetes mellitus	0.000148	0.000682	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000146	0.000674	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000141	0.000651	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000136	0.000626	CcSEcCtD
Dinoprost Tromethamine—Rash—Ramipril—type 2 diabetes mellitus	0.000135	0.000621	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000135	0.00062	CcSEcCtD
Dinoprost Tromethamine—Headache—Ramipril—type 2 diabetes mellitus	0.000134	0.000617	CcSEcCtD
Dinoprost Tromethamine—Nausea—Ramipril—type 2 diabetes mellitus	0.000127	0.000585	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.57e-05	6.53e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AVP—type 2 diabetes mellitus	1.57e-05	6.52e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.57e-05	6.52e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HK1—type 2 diabetes mellitus	1.57e-05	6.51e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.56e-05	6.5e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.56e-05	6.47e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.56e-05	6.47e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.56e-05	6.47e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.56e-05	6.47e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.54e-05	6.4e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—INS—type 2 diabetes mellitus	1.54e-05	6.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AVP—type 2 diabetes mellitus	1.54e-05	6.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.54e-05	6.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.54e-05	6.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.54e-05	6.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.54e-05	6.37e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.53e-05	6.36e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.53e-05	6.36e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.53e-05	6.36e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.53e-05	6.33e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.53e-05	6.33e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—APOB—type 2 diabetes mellitus	1.52e-05	6.31e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.52e-05	6.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—LPA—type 2 diabetes mellitus	1.52e-05	6.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GCKR—type 2 diabetes mellitus	1.52e-05	6.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.52e-05	6.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.52e-05	6.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.51e-05	6.28e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.51e-05	6.26e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.51e-05	6.26e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.49e-05	6.21e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.49e-05	6.19e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.49e-05	6.18e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.49e-05	6.18e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—APOB—type 2 diabetes mellitus	1.49e-05	6.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.49e-05	6.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.48e-05	6.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.48e-05	6.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.48e-05	6.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.48e-05	6.14e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.48e-05	6.14e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.47e-05	6.1e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.46e-05	6.07e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.46e-05	6.07e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ALDOB—type 2 diabetes mellitus	1.45e-05	6.03e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.45e-05	6.02e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—LPL—type 2 diabetes mellitus	1.45e-05	6.02e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.42e-05	5.89e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—LPL—type 2 diabetes mellitus	1.42e-05	5.89e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.42e-05	5.89e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.41e-05	5.87e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.4e-05	5.8e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.39e-05	5.77e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.39e-05	5.77e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—INS—type 2 diabetes mellitus	1.39e-05	5.77e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.39e-05	5.75e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.38e-05	5.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.37e-05	5.67e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.36e-05	5.65e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.36e-05	5.63e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.35e-05	5.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.35e-05	5.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GLP1R—type 2 diabetes mellitus	1.35e-05	5.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.34e-05	5.58e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.34e-05	5.57e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.34e-05	5.55e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.34e-05	5.55e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.33e-05	5.53e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.33e-05	5.53e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.31e-05	5.43e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.31e-05	5.43e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—C3—type 2 diabetes mellitus	1.31e-05	5.42e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.3e-05	5.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.29e-05	5.35e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—C3—type 2 diabetes mellitus	1.28e-05	5.31e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—C3—type 2 diabetes mellitus	1.28e-05	5.31e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.28e-05	5.3e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—RELA—type 2 diabetes mellitus	1.27e-05	5.28e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.26e-05	5.23e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.25e-05	5.21e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.25e-05	5.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.24e-05	5.16e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AGT—type 2 diabetes mellitus	1.24e-05	5.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CPT1A—type 2 diabetes mellitus	1.24e-05	5.13e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—MTR—type 2 diabetes mellitus	1.24e-05	5.13e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.23e-05	5.13e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.22e-05	5.06e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.22e-05	5.06e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.22e-05	5.06e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.22e-05	5.06e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.22e-05	5.06e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.22e-05	5.05e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.22e-05	5.05e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—APOE—type 2 diabetes mellitus	1.22e-05	5.05e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—LEP—type 2 diabetes mellitus	1.22e-05	5.05e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AGT—type 2 diabetes mellitus	1.21e-05	5.04e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.21e-05	5.04e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NAMPT—type 2 diabetes mellitus	1.21e-05	5.03e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—AKT1—type 2 diabetes mellitus	1.21e-05	5.02e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GCK—type 2 diabetes mellitus	1.2e-05	5e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HBA1—type 2 diabetes mellitus	1.2e-05	5e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—LIPC—type 2 diabetes mellitus	1.2e-05	5e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.2e-05	4.99e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.2e-05	4.97e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.19e-05	4.96e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.19e-05	4.96e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—LEP—type 2 diabetes mellitus	1.19e-05	4.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—APOE—type 2 diabetes mellitus	1.19e-05	4.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.19e-05	4.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.19e-05	4.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.18e-05	4.88e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.18e-05	4.88e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.17e-05	4.88e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CETP—type 2 diabetes mellitus	1.16e-05	4.82e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.16e-05	4.8e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.15e-05	4.78e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.15e-05	4.76e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.15e-05	4.76e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.15e-05	4.76e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.14e-05	4.73e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.13e-05	4.69e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.12e-05	4.66e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.12e-05	4.66e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.08e-05	4.5e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.08e-05	4.5e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SNAP25—type 2 diabetes mellitus	1.08e-05	4.48e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PSMD6—type 2 diabetes mellitus	1.08e-05	4.48e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SREBF1—type 2 diabetes mellitus	1.08e-05	4.48e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.07e-05	4.45e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.06e-05	4.41e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.06e-05	4.41e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CTGF—type 2 diabetes mellitus	1.06e-05	4.4e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.05e-05	4.36e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HMGCR—type 2 diabetes mellitus	1.05e-05	4.36e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.04e-05	4.33e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—INS—type 2 diabetes mellitus	1.04e-05	4.31e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.03e-05	4.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.03e-05	4.27e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.03e-05	4.27e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.03e-05	4.26e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.02e-05	4.24e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—INS—type 2 diabetes mellitus	1.02e-05	4.22e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—INS—type 2 diabetes mellitus	1.02e-05	4.22e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IGF1—type 2 diabetes mellitus	1e-05	4.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKT2—type 2 diabetes mellitus	1e-05	4.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL2—type 2 diabetes mellitus	1e-05	4.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1e-05	4.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1e-05	4.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SRC—type 2 diabetes mellitus	9.99e-06	4.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP2E1—type 2 diabetes mellitus	9.87e-06	4.1e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.83e-06	4.08e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.83e-06	4.08e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.83e-06	4.08e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.83e-06	4.08e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.79e-06	4.06e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.79e-06	4.06e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.77e-06	4.06e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SLC2A1—type 2 diabetes mellitus	9.76e-06	4.05e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP1A2—type 2 diabetes mellitus	9.76e-06	4.05e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.73e-06	4.04e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.67e-06	4.01e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.54e-06	3.96e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP3A4—type 2 diabetes mellitus	9.52e-06	3.95e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.48e-06	3.93e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SLC2A4—type 2 diabetes mellitus	9.36e-06	3.89e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GCG—type 2 diabetes mellitus	9.36e-06	3.89e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.34e-06	3.88e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.34e-06	3.88e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.11e-06	3.78e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.11e-06	3.78e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SRC—type 2 diabetes mellitus	9.01e-06	3.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.93e-06	3.71e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.92e-06	3.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.92e-06	3.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.92e-06	3.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.92e-06	3.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.78e-06	3.64e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.76e-06	3.63e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL6—type 2 diabetes mellitus	8.68e-06	3.6e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—RELA—type 2 diabetes mellitus	8.57e-06	3.56e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—RELA—type 2 diabetes mellitus	8.39e-06	3.48e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.39e-06	3.48e-05	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—AKT1—type 2 diabetes mellitus	8.14e-06	3.38e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.07e-06	3.35e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	8.07e-06	3.35e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.05e-06	3.34e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	8.03e-06	3.33e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.01e-06	3.32e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	7.92e-06	3.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.9e-06	3.28e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.81e-06	3.24e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.73e-06	3.21e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	7.69e-06	3.19e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.68e-06	3.19e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.64e-06	3.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.64e-06	3.17e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.57e-06	3.14e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.57e-06	3.14e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.52e-06	3.12e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.52e-06	3.12e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	7.48e-06	3.11e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	7.35e-06	3.05e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.31e-06	3.03e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.23e-06	3e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	7.19e-06	2.98e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	7.17e-06	2.97e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.15e-06	2.97e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.15e-06	2.97e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.09e-06	2.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.08e-06	2.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.08e-06	2.94e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	6.98e-06	2.9e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.94e-06	2.88e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.94e-06	2.88e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	6.89e-06	2.86e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SRC—type 2 diabetes mellitus	6.74e-06	2.8e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL6—type 2 diabetes mellitus	6.73e-06	2.79e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	6.61e-06	2.75e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SRC—type 2 diabetes mellitus	6.6e-06	2.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.6e-06	2.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.56e-06	2.72e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	6.49e-06	2.69e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.42e-06	2.67e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.42e-06	2.67e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	6.28e-06	2.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.21e-06	2.58e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	6.18e-06	2.56e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	6.16e-06	2.56e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	6.09e-06	2.53e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL6—type 2 diabetes mellitus	6.07e-06	2.52e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.02e-06	2.5e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.91e-06	2.45e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.9e-06	2.45e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.9e-06	2.45e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.78e-06	2.4e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.78e-06	2.4e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.6e-06	2.32e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	5.36e-06	2.23e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	5.26e-06	2.18e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	4.82e-06	2e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.61e-06	1.91e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	4.61e-06	1.91e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL6—type 2 diabetes mellitus	4.54e-06	1.88e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL6—type 2 diabetes mellitus	4.44e-06	1.84e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.44e-06	1.84e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	4.22e-06	1.75e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.19e-06	1.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.1e-06	1.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.1e-06	1.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	2.12e-06	8.8e-06	CbGpPWpGaD
